1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Inquiry-Based Stress Reduction on Well-being and Views on Risk-Reducing Surgery Among Women With BRCA Variants in Israel : A Randomized Clinical Trial

      research-article
      , MPH 1 , , MSc 1 , , PhD 2 , , BA 2 , , MD, PhD 3 , , PhD 1 ,
      JAMA Network Open
      American Medical Association

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Does the inquiry-based stress reduction technique improve the psychological well-being, sleep quality, and psychosocial variables and change views on risk-reducing surgery in women in Israel with BRCA1/ BRCA2 variants?

          Findings

          This randomized clinical trial including 100 patients using an IBSR intervention found that IBSR improved the well-being and sleep quality of women with BRCA1/ BRCA2 variants. After the intervention, the participants who underwent IBSR had more favorable view on risk-reducing oophorectomy and mastectomy.

          Meaning

          These findings suggest that IBSR may be used as a tool to enhance the psychological well-being of women with BRCA variants and support them in considering risk-reducing surgery.

          Abstract

          This randomized clinical trial assessed the effect of an inquiry-based stress reduction intervention on psychological well-being, sleep quality, and receptivity to risk-reducing surgical procedures in asymptomatic women with BRCA variants.

          Abstract

          Importance

          The high risk for breast and ovarian cancers conferred by being a carrier of BRCA1 or BRCA2 germline variant can negatively impact physical and psychological well-being. Novel nonpharmacological interventions on well-being in women with BRCA variants have rarely been reported.

          Objective

          To determine the effect of a 12-week inquiry-based stress reduction (IBSR) program on psychological well-being, sleep quality, psychosocial variables, and attitudes toward risk-reducing surgical procedures among women in Israel who carried BRCA variants.

          Design, Setting, and Participants

          This randomized clinical trial had a 12-week intervention period and a 12-week follow-up period. It was conducted between April 1, 2017, and July 31, 2020. Participants were recruited from the Meirav Breast Center at the Sheba Medical Center, Israel, and the intervention was conducted in Tel Aviv, Israel. The cohort included women with BRCA variants. Data were analyzed from August 1 to December 1, 2020.

          Interventions

          Women were randomly assigned to the 12-week IBSR program or standard care. The IBSR technique is based on the skills of mindfulness, inquiry, and cognitive reframing. The intervention included standardized, weekly group meetings conducted throughout 12 weeks. Standard care included semi-annual breast examinations and breast magnetic resonance imaging (alternating), a gynecological examination, a transvaginal ultrasonographic examination, and CA-125 serum determination. Differences between the groups were tested using mixed-effects models in an intent to treat analysis.

          Main Outcomes and Measures

          The primary outcome was psychological well-being, including 6 parameters: autonomy, personal growth, positive relationships, control of the environment, goals in life, and self-acceptance. Secondary outcomes included sleep quality, attitudes toward risk-reducing surgical procedures, and psychosocial variables. Questionnaires were administered at baseline (T1), at completion of the 12-week intervention (T2), and 12 weeks after completion of the intervention (T3).

          Results

          Overall, 100 women (mean [SD] age, 41.37 [11.06] years) completed the study, with 50 randomized to the intervention group and 50 randomized to the control group. Mean (SD) time from variant discovery was 4.7 (3.3) years. There were no differences between the intervention and control groups in baseline mean (SD) scores of psychological well-being parameters (autonomy: 55.20 [11.12] vs 56.77 [9.90]; environmental control: 56.30 [11.98 vs 58.51 [11.41]; positive relationships: 63.10 [15.91] vs 68.10 [9.86]; goals in life: 60.00 [14.12] vs 64.82 [10.57]; self-acceptance: 55.02 [16.62] vs 60.32 [13.50]) except personal growth (63.70 [14.66] vs 68.85 [8.07]). The IBSR group, compared with the control group, experienced better mean (SD) scores on all psychological well-being parameters at T2 (autonomy: 63.64 [8.35] vs 54.73 [10.41]; environmental control: 63.95 [10.05] vs 57.45 [11.43]; personal growth: 73.00 [8.34] vs 65.76 [10.95]; positive relationships 71.17 [9.99] vs 65.06 [12.58]; goals in life: 67.57 [8.88] vs 61.18 [12.87]; self-acceptance: 66.93 [11.15] vs 58.09 [15.55]) and at T3 (autonomy: 62.68 [9.05] vs 56.12 [10.64]; environmental control: 64.55 [10.28] vs 59.35 [12.98]; personal growth: 72.00 [8.06] vs 67.15 [11.82]; positive relationships: 71.24 [9.78] vs 66.92 [12.37]; goals in life: 68.33 [8.54] vs 62.92 [13.24]; self-acceptance: 66.84 [11.35] vs 58.97 [17.03]). Individuals in the IBSR group also experienced statistically significant improvements in sleep quality (mean [SD]: T1, 7.35 [3.97]; T3, 4.63 [3.21], P < .001), whereas the control group experienced no statistically significant difference. Women in the intervention group had a more favorable consideration of risk-reducing oophorectomy, from 7 women (14%) who refused to consider oophorectomy at T1 to 1 woman (2%) who refused to consider it at T3 ( P = .04), and similar change in consideration of mastectomy: from 23 women (46%) who refused to consider mastectomy at T1 to 13 women (29%) who refused to consider it at T3 ( P < .001).

          Conclusions and Relevance

          This randomized clinical trial found that IBSR improved psychological well-being and led to a more favorable view on risk-reducing surgical procedures for at least 6 months among women in Israel who carried BRCA variants. These results suggest that IBSR may be implemented as a self-practice tool to enhance the well-being of individuals who carry BRCA variants and support them in their decision-making processes.

          Trial Registration

          ClinicalTrials.gov Identifier: NCT03162276

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Coefficient alpha and the internal structure of tests

              Psychometrika, 16(3), 297-334
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                28 December 2021
                December 2021
                28 December 2021
                : 4
                : 12
                : e2139670
                Affiliations
                [1 ]Department of Health Promotion, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                [2 ]Department of Genetics, Stanford University School of Medicine, Stanford, California
                [3 ]Suzanne Levy-Gertner Oncogenetics Unit, Sheba Medical Center, Ramat Gan, Israel
                Author notes
                Article Information
                Accepted for Publication: October 21, 2021.
                Published: December 28, 2021. doi:10.1001/jamanetworkopen.2021.39670
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Landau C et al. JAMA Network Open.
                Corresponding Author: Shahar Lev-Ari, PhD, Department of Health Promotion, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel ( leva@ 123456tauex.tau.ac.il ).
                Author Contributions: Ms Landau and Dr Lev-Ari had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr Friedman contributed equally with Dr Lev-Ari as co–last author.
                Concept and design: Landau, Lev-Ari.
                Acquisition, analysis, or interpretation of data: All authors.
                Drafting of the manuscript: Landau, Novak, Friedman, Lev-Ari.
                Critical revision of the manuscript for important intellectual content: Landau, Novak, Ganz, Rolnik, Friedman.
                Statistical analysis: Landau, Novak.
                Obtained funding: Landau.
                Administrative, technical, or material support: Landau, Novak, Rolnik.
                Supervision: Landau, Friedman, Lev-Ari.
                Conflict of Interest Disclosures: Dr Ganz serving as a cofounder of Xthena Partners and InquiryRX. Dr Rolnik reported serving as a cofounder of InquiryRx. Dr Lev-Ari reported receiving grants from “The Work” Foundation during the conduct of the study. No other disclosures were reported.
                Funding/Support: This study was partially supported by Israel Cancer Association (grant No. 20200049), and by “The Work” Foundation (grant No. TWF-TAU).
                Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Data Sharing Statement: See Supplement 3.
                Additional Contributions: We thank the participants for their cooperation in taking part in the study. Alina Rosenberg assisted with statistical analysis. Dafna Ben Bashat, PhD, Zeev Usher, Orly Houli, Nehama Teichtal, Yael Tal, Nitsan Dror, Alex Burnley, Leah Mor, Haddas Roth, Nomi Matmon, Tali Lev, Yaki Tessel, Ophir Beren, Miriam Sonnenfeld, Israela Corcos, Tamar Moskovich, Liora Ben Simhon‎, Mira Kremer, Irena Zelmanov assisted in inquiry-based stress reduction training with participants. None of these individuals were compensated for their work.
                Article
                zoi211116
                10.1001/jamanetworkopen.2021.39670
                8715352
                34962562
                e4d36edc-76d3-4c96-9055-56b36691cc4c
                Copyright 2021 Landau C et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 7 July 2021
                : 21 October 2021
                Categories
                Research
                Original Investigation
                Online Only
                Complementary and Alternative Medicine

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content167

                Cited by3

                Most referenced authors1,292